Paper Review Records
All Paper Review Records
15 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
70
days
Phase I Evaluation of Siltartoxatug, a First‐in‐Class Anti‐Tetanus Monoclonal Antibody: Safety, Pharmacokinetics and Pharmacodynamics in Healthy Australian and Chinese Populations
Authors
Xinyu Liu; Zhigang Liu; Xiaohu Kuang; Yueming Wang; Xiaoyi Liu; Jiyuan Ding; Xia Zhou; Xin Zhou; Qianyu Liang; Meizhuo Zhang; Hao Zhao; Qingqing Tan; Weihong Zheng; Huaxin Liao; Charlotte Lemech; Wanmei WangShow moreShow less
Affiliations
1. Zhuhai Trinomab Pharmaceutical Co., Ltd. Zhuhai China; 2. The Fifth Affiliated Hospital Sun Yat‐sen University Zhuhai China; 3. Present address: Cancer Center, The Tenth Affiliated Hospital Southern Medical University (Dongguan People's Hospital) Dongguan China; 4. Scientia Clinical Research Ltd. Sydney AustraliaShow moreShow less
195
days
Exposure–Response Analysis of Enfortumab Vedotin Plus Pembrolizumab as First‐Line Therapy for Locally Advanced or Metastatic Urothelial Cancer
Authors
Vaishali L. Chudasama; Helen Kastrissios; Hossam Kadry; Daping Zhang; Salaheldin Hamed; Srinivasu Poondru; Souvik Bhattacharya; Russ Wada; Amit Garg; Yen Lin ChiaShow moreShow less
Affiliations
1. Pfizer Inc New York New York USA; 2. QuanTx Consulting Mountain View California USA; 3. Astellas Pharma Northbrook Illinois USA; 4. BeOne Medicines San Carlos California USAShow moreShow less
103
days
Effects of Fomepizole on Acetaminophen Oxidative Metabolism: A Randomized, Crossover Study in Human Volunteers
Authors
Sidharth Anand; Nicholas A. Buckley; Paul Stathakis; Laura James; Larry Parker; Mitchell R. McGill; Angela L ChiewShow moreShow less
Affiliations
1. Faculty of Medicine The University of New South Wales Sydney New South Wales Australia; 2. Faculty of Medicine and Health The University of Sydney Camperdown New South Wales Australia; 3. NSW Health Pathology, Prince of Wales Hospital Randwick New South Wales Australia; 4. Department of Pediatrics, College of Medicine University of Arkansas for Medical Sciences Little Rock Arkansas USA; 5. Acetaminophen Toxicity Diagnostics, LLC Little Rock Arkansas USA; 6. Department of Environmental Health Sciences, Fay W. Boozman College of Public Health University of Arkansas for Medical Sciences Little Rock Arkansas USA; 7. Department of Pharmacology and Toxicology, College of Medicine University of Arkansas for Medical Sciences Little Rock Arkansas USA; 8. Department of Clinical Toxicology Prince of Wales Hospital Randwick New South Wales AustraliaShow moreShow less
117
days
Epcoritamab Step‐Up Dosing Regimen Selection and Optimization Using Repeated Time‐to‐Event Modeling for Cytokine Release Syndrome Risk Mitigation
Authors
Tommy Li; Andrew Tredennick; Daniel Polhamus; Matthew Putnins; Sihang Liu; Kinjal Sanghavi; Craig J. Thalhauser; Apurvasena Parikh; Behnam Noorani; Mohamed‐Eslam F. Mohamed; Chris Le Gallo; Brian Elliott; Manish Gupta; Steven XuShow moreShow less
Affiliations
1. Genmab Princeton New Jersey USA; 2. Metrum Research Group Boston Massachusetts USA; 3. AbbVie Inc. North Chicago Illinois USAShow moreShow less
125
days
From Executor to Orchestrator: The Pharmacology Scientist in the Age of Agentic AI
Authors
Michael McCoy; Matthew McCoyShow moreShow less
Affiliations
1. Drug Metabolism and Pharmacokinetics & Modeling, Takeda Development Center Americas Cambridge Massachusetts USA; 2. Independent Researcher Kansas City Missouri USAShow moreShow less
9
days
The Future of Clinical Pharmacology: The Right Medicine at the Right Dose for Each Patient
Authors
Richard W. PeckShow moreShow less
Affiliations
1. Department of Pharmacology & Toxicology University of Liverpool Liverpool UKShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review62 days
Median65 days